Pomalidomide (Pom) Plus Low-Dose Dexamethasone (Lodex) After Lenalidomide (Len)-Based Second-Line (2l) Treatment (Tx) In Patients (Pts) With Relapsed/Refractory Multiple Myeloma (Rrmm): Analysis Of Progression-Free Survival (Pfs) By Level Of Disease Control.
JOURNAL OF CLINICAL ONCOLOGY（2017）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要